Invivyd, Inc. - Common Stock (NQ:IVVD)

0.5904 +0.0012 (+0.20%)

Delayed Quote Updated: 12:30 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Invivyd, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI

February 08, 2023

WHY: New York, NY - (NewMediaWire) - February 08, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc....

Via NewMediaWire

Topics Lawsuit

IVVD INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. and Announces Opportunity for Investors with Significant Losses to Lead Case

February 08, 2023

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD)

February 08, 2023

From Law Offices of Howard G. Smith

Via Business Wire

INVIVYD SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI

February 07, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) Investors

February 06, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI

February 05, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against RYVYL, and Invivyd and Encourages Investors to Contact the Firm

February 03, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) Investors

February 03, 2023

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) Investors

February 03, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

Invivyd Announces Changes to Executive Team

February 03, 2023

From Invivyd

Via GlobeNewswire

INVIVYD ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Invivyd, Inc. and Encourages Investors to Contact the Firm

February 02, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) on Behalf of Investors

February 02, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

Bronstein, Gewirtz & Grossman, LLC Notifies Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) Investors of Class Action and to Actively Participate

February 02, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

NATIONALLY RANKED ROSEN LAW FIRM Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI

February 02, 2023

From Rosen Law Firm

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) on Behalf of Investors

February 01, 2023

From Law Offices of Howard G. Smith

Via Business Wire

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Invivyd, Inc. (IVVD) f/k/a Adagio Therapeutics, Inc.

February 01, 2023

From Robbins LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) on Behalf of Investors

February 01, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

February 01, 2023

From The Schall Law Firm

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

January 31, 2023

From The Schall Law Firm

Via Business Wire

IVVD INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case

January 31, 2023

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 23, 2023

Via Benzinga

Invivyd Presented Joint Industry Rationale on Potential Expedited Development Pathways for Monoclonal Antibodies at FDA-EMA Workshop

December 19, 2022

From Invivyd

Via GlobeNewswire

Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical Officer

December 06, 2022

From Invivyd

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 21, 2022

Via Benzinga

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗

November 22, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical Development in Infectious Diseases Including COVID-19

November 17, 2022

From Invivyd

Via GlobeNewswire

NASDAQ:IVVD Investor Alert: Investigation over Potential Wrongdoing at Invivyd, Inc. ↗

November 11, 2022

San Diego, CA -- (SBWIRE) -- 11/11/2022 -- Certain directors of Invivyd, Inc. are under investigation over potential breaches of fiduciary duties.

Via SBWire

Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights

November 10, 2022

From Invivyd

Via GlobeNewswire

Invivyd to Participate in Fireside Chat at the Jefferies London Healthcare Conference

November 09, 2022

From Invivyd

Via GlobeNewswire

Invivyd Announces the Appointment of Christine Lindenboom to Board of Directors

October 24, 2022

From Invivyd

Via GlobeNewswire

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.